Literature DB >> 35680727

EIF4A3-induced circFIP1L1 represses miR-1253 and promotes radiosensitivity of nasopharyngeal carcinoma.

Xiangqi Zhou1, Guangjin Yuan1, Yangjie Wu2, Sijia Yan1, Qingshan Jiang3, Sanyuan Tang4.   

Abstract

BACKGROUND: Radiation is currently used to be a mainstay of salvage therapy for nasopharyngeal carcinoma (NPC), however, development of radioresistance largely limits the radiation efficacy. Circular RNAs (circRNAs) have been shown to affect NPC progression, but its role in radioresistance remain unclear.
METHODS: The circular structure of circFIP1L1(circ_0069740) was verified by RNA-sequencing, RT-PCR based on gDNA or cDNA, RNase R treatment, and actinomycin D treatment. Cellular localization of circFIP1L1 and miR-1253 was detected by nucleoplasmic separation and/or fluorescence in situ hybridization. Expression of non-coding RNAs and mRNAs was detected by qRT-PCR, protein expression was detected by Western blot. Functionally, EdU, CCK-8, and colony formation experiments were employed to assess cell proliferation, flow cytometry was adopted to estimate cell cycle and apoptosis. Xenograft tumor growth was performed to detect the role of circFIP1L1 in vivo. Mechanistically, we examined the interplay between miR-1253 and circFIP1L1 or EIF4A3 through dual-luciferase reporter assay. The potential regulatory impacts of EIF4A3 on circFIP1L1 or PTEN was examined by RNA immunoprecipitation and RNA pull-down assays.
RESULTS: CircFIP1L1 overexpression and miR-1253 knockdown repressed NPC cell proliferation, facilitated NPC cell apoptosis, and enhanced NPC radiosensitivity. Mechanistically, circFIP1L1 was revealed to repress miR-1253 by binding to it, and EIF4A3 is a target gene of miR-1253. CircFIP1L1 regulated NPC proliferation, apoptosis, and radiosensitivity through miR-1253/EIF4A3. Moreover, we found that EIF4A3 bound to FIP1L1 mRNA transcript and induced circFIP1L1 formation, and thus stabilizing PTEN mRNA.
CONCLUSION: Our findings suggested that EIF4A3-induced circFIP1L1 repressed NPC cell proliferation, facilitated NPC cell apoptosis, and enhanced NPC radiosensitivity by miR-1253.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Apoptosis; EIF4A; Nasopharyngeal carcinoma; PTEN; Proliferation; Radiosensitivity; circFIP1L1; miR-1253

Mesh:

Substances:

Year:  2022        PMID: 35680727     DOI: 10.1007/s00018-022-04350-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  40 in total

1.  How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

Authors:  Shu-Zhen Lai; Wen-Fei Li; Lei Chen; Wei Luo; Yuan-Yuan Chen; Li-Zhi Liu; Ying Sun; Ai-Hua Lin; Meng-Zhong Liu; Jun Ma
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-17       Impact factor: 7.038

Review 2.  Nasopharyngeal carcinoma.

Authors:  Sophia C Kamran; Nadeem Riaz; Nancy Lee
Journal:  Surg Oncol Clin N Am       Date:  2015-04-11       Impact factor: 3.495

Review 3.  Circular RNA and its mechanisms in disease: From the bench to the clinic.

Authors:  Bing Han; Jie Chao; Honghong Yao
Journal:  Pharmacol Ther       Date:  2018-02-14       Impact factor: 12.310

Review 4.  Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.

Authors:  Anne W M Lee; Brigette B Y Ma; Wai Tong Ng; Anthony T C Chan
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

5.  A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.

Authors:  Y P Chen; Z X Wang; L Chen; X Liu; L L Tang; Y P Mao; W F Li; A H Lin; Y Sun; J Ma
Journal:  Ann Oncol       Date:  2014-10-29       Impact factor: 32.976

6.  International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma.

Authors:  Anne W Lee; Wai Tong Ng; Jian Ji Pan; Chi-Leung Chiang; Sharon S Poh; Horace C Choi; Yong Chan Ahn; Hussain AlHussain; June Corry; Cai Grau; Vincent Grégoire; Kevin J Harrington; Chao Su Hu; Dora L Kwong; Johannes A Langendijk; Quynh Thu Le; Nancy Y Lee; Jin Ching Lin; Tai Xiang Lu; William M Mendenhall; Brian O'Sullivan; Enis Ozyar; Lester J Peters; David I Rosenthal; Giuseppe Sanguineti; Yoke Lim Soong; Yungan Tao; Sue S Yom; Joseph T Wee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-07-02       Impact factor: 7.038

Review 7.  Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma.

Authors:  Eugenia L L Yeo; You Quan Li; Khee-Chee Soo; Joseph T S Wee; Melvin L K Chua
Journal:  Chin Clin Oncol       Date:  2018-04

Review 8.  Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer.

Authors:  Bing Chen; Shenglin Huang
Journal:  Cancer Lett       Date:  2018-01-09       Impact factor: 8.679

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 10.  Circular RNAs in cancer: opportunities and challenges in the field.

Authors:  L S Kristensen; T B Hansen; M T Venø; J Kjems
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.